Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics, holds 169.78K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 64.26K shares in Strongbridge Biopharma (Ticker: SBBP).
What is the percentage of profitable transactions made by Jeffrey W. Sherman?
The percentage of profitable transactions made by Jeffrey W. Sherman is 50%.
What is the average return per transaction made by Jeffrey W. Sherman?
The average return per transaction made by Jeffrey W. Sherman is 32.90%.
What stocks does Jeffrey W. Sherman hold?
Jeffrey W. Sherman holds: HZNP, SBBP, XERS, LRMR, INSYQ stocks.
What was Jeffrey W. Sherman’s latest transaction?
Jeffrey W. Sherman latest transaction was an Uninformative Buy of ―.
What was Jeffrey W. Sherman's most profitable transaction?
Jeffrey W. Sherman’s most profitable transaction was an Informative Buy of XERS stock on November 29, 2023. The return on the trade was 88.00%.
What is Jeffrey W. Sherman's role in Horizon Therapeutics?
Jeffrey W. Sherman's role in Horizon Therapeutics is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.